A kidney has the ability to regenerate itself after a variety of renal injuries. Mesenchymal
stem cells (MSCs) have been shown to ameliorate tissue damages during renal injuries and …

Mesenchymal stem cells (MSCs) have immunomodulatory and regenerative effects in many
organs, including the kidney. Emerging evidence has shown that the trophic effects from …

Novel therapies are urgently needed to address the rising incidence and prevalence of
acute kidney injury (AKI) and chronic kidney disease (CKD). Mesenchymal stem/stromal …

Acute kidney injury (AKI) causes a lot of harm to human health but is treated by only
supportive therapy in most cases. Recent evidence shows that mesenchymal stem cells …

Introduction: Transplantation of autologous mesenchymal stem cells (MSCs) has been
shown to attenuate renal injury and dysfunction in several animal models, and its efficacy is …

Acute kidney injury (AKI) and chronic kidney disease (CKD) are rising in global prevalence
and cause significant morbidity for patients. Current treatments are limited to slowing instead …

Background Ischemia/reperfusion injury is the leading cause of acute kidney injury (AKI).
The current standard of care focuses on supporting kidney function, stating the need for …

Every year 13.3 million people suffer acute kidney injury (AKI), which is associated with a
high risk of death or development of long-term chronic kidney disease (CKD) in a substantial …

Abstract Background Mesenchymal stromal cells (MSCs) and renal stem/progenitors
improve the recovery of acute kidney injury (AKI) mainly through the release of paracrine …

Extracellular vesicles (EVs) are membranous vesicles containing active proteins, lipids, and
different types of genetic material such as miRNAs, mRNAs, and DNAs related to the …